Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
Go back to Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study| (NASDAQ: KRYS) | Delayed: 341.12 -25.73 (7.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.85 | 52 Week High | $ | |||
| Open | $364.66 | 52 Week Low | $ | |||
| Day High | $367.30 | P/E | N/A | |||
| Day Low | $340.55 | EPS | $ | |||
| Volume | 488,644 | |||||

